Production of protein-associated DNA breaks by 10-[diethylaminopropylamino]-6-methyl-5H-pyrido[3',4':4,5]pyrrolo [2,3-g]isoquinoline in cultured L1210 cells and in isolated nuclei: comparison with other topoisomerase II inhibitors.

10-[3-Diethylaminopropylamino]-6-methyl-5H-pyrido[3',4':4,5] pyrrolo[2,3-g]isoquinoline (PZE) is an ellipticine derivative currently in clinical trials. PZE has been postulated to produce cellular DNA lesions by an uncommon mechanism. PZE-induced DNA damage was further investigated in L1210 cells in culture. PZE was highly cytotoxic for these cells (90% inhibitory concentration = 3.1 microM). The effects of PZE on cellular DNA were studied first by alkaline sucrose sedimentation, in comparison with those of 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA). Like m-AMSA, PZE induced DNA strand breaks which were detected without a proteolytic treatment of the cell lysate. This result rules out the existence of covalent protein bridges sealing DNA termini at the break sites. PZE was less active than m-AMSA. DNA fragmentation was maximum at 5 microM and was lower at higher concentrations. The DNA effects of PZE were also studied by alkaline elution, and compared with those of Adriamycin and m-AMSA. Like Adriamycin, PZE induced single-strand breaks (SSBs) in a bell-shaped manner with respect to drug concentration. The maximum SSB frequency [1784 +/- 370 (SEM) rad equivalents)] was obtained at 16 microM. The kinetics of SSB reversion after drug removal was slower than in the case of m-AMSA. Similar bell-shaped curves were obtained for PZE-induced double-strand breaks and DNA-protein cross-links. PZE induced more double-strand breaks per SSB than did m-AMSA. However, as in the case of m-AMSA, PZE induced equal SSB and DNA-protein cross-link frequencies. These results suggest that PZE induces DNA breaks by inhibiting topoisomerase II as do other antitumor intercalators.

[1]  C. Larsen,et al.  The in vitro involvement of topoisomerase II in the activity of aza-ellipticine analogues is not correlated with drug activity on isolated nuclei. , 1986, Biochemical pharmacology.

[2]  K. Kohn,et al.  Effects of DNA intercalating agents on topoisomerase II induced DNA strand cleavage in isolated mammalian cell nuclei. , 1985, Biochemistry.

[3]  K. Kohn,et al.  Effects of the DNA intercalators 4'-(9-acridinylamino)methanesulfon-m-anisidide and 2-methyl-9-hydroxyellipticinium on topoisomerase II mediated DNA strand cleavage and strand passage. , 1985, Biochemistry.

[4]  F. Calvo,et al.  Differential effects of ellipticine and aza-analogue derivatives on cell cycle progression and survival of BALB/c 3T3 cells released from serum starvation or thymidine double block. , 1985, Cancer research.

[5]  P. Casellas,et al.  Optimal elimination of leukemic T cells from human bone marrow with T101-ricin A-chain immunotoxin. , 1985, Blood.

[6]  C. Larsen,et al.  BD-40, an ellipticine-related DNA intercalative agent induces DNA-protein bridges in vivo. , 1984, Nucleic acids research.

[7]  K. Kohn,et al.  Formation and rejoining of deoxyribonucleic acid double-strand breaks induced in isolated cell nuclei by antineoplastic intercalating agents. , 1984, Biochemistry.

[8]  K. Kohn,et al.  Changes in deoxyribonucleic acid linking number due to treatment of mammalian cells with the intercalating agent 4'-(9-acridinylamino)methanesulfon-m-anisidide. , 1984, Biochemistry.

[9]  C. Larsen,et al.  Le BD-40, intercalant dérivé des aza-9 ellipticines, induit dans l'ADN cellulaire des cassures associées à des pontages protéiques. , 1984 .

[10]  L. Liu,et al.  Intercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. , 1984, The Journal of biological chemistry.

[11]  M. Israel,et al.  Relationship of adriamycin concentrations to the DNA lesions induced in hypoxic and euoxic L1210 cells. , 1983, Cancer research.

[12]  M. Maftouh,et al.  In Vitro Oxidative Activation: A Model for the Cytotoxic Action of 9-Hydroxy Ellipticine Derivatives , 1983 .

[13]  M. Alley,et al.  Improved detection of drug cytotoxicity in the soft agar colony formation assay through use of a metabolizable tetrazolium salt. , 1982, Life sciences.

[14]  K. Kohn,et al.  Protein-associated deoxyribonucleic acid strand breaks produced in mouse leukemia L1210 cells by ellipticine and 2-methyl-9-hydroxyellipticinium. , 1982, Biochemical pharmacology.

[15]  K. Kohn,et al.  Ellipticine-induced protein-associated DNA breaks in isolated L1210 nuclei. , 1982, Biochimica et biophysica acta.

[16]  Y. Pommier,et al.  The formation and resealing of intercalator-induced DNA strand breaks in isolated L1210 cell nuclei. , 1982, Biochemical and biophysical research communications.

[17]  K. Kohn,et al.  Protein-associated deoxyribonucleic acid strand breaks in L1210 cells treated with the deoxyribonucleic acid intercalating agents 4'-(9-acridinylamino) methanesulfon-m-anisidide and adriamycin. , 1981, Biochemistry.

[18]  J. Chermann,et al.  Structure-activity relationships in a series of newly synthesized 1-amino-substituted ellipticine derivatives. , 1980, Journal of Medicinal Chemistry.

[19]  K. Kohn,et al.  X-ray induced DNA double strand break production and repair in mammalian cells as measured by neutral filter elution. , 1979, Nucleic acids research.

[20]  K. Kohn,et al.  Qualitative and quantitative aspects of intercalator-induced DNA strand breaks. , 1979, Biochimica et biophysica acta.

[21]  C. Paoletti,et al.  Ellipticine and derivatives induce breakage of L1210 cells DNA in vitro. , 1979, Biochemical pharmacology.

[22]  J. Loike,et al.  Effect of VP-16-213 on the intracellular degradation of DNA in HeLa cells. , 1976, Biochemistry.

[23]  K W Kohn,et al.  Intercalative binding of ellipticine to DNA. , 1975, Cancer research.

[24]  C. Paoletti,et al.  A new antitumoral agent: 9-hydroxyellipticine. Possibility of a rational design of anticancerous drugs in the series of DNA intercalating drugs. , 1974, Proceedings of the National Academy of Sciences of the United States of America.